183 related articles for article (PubMed ID: 30575938)
1. Preclinical pharmacokinetic study of a novel lipid-lowering agent, IMM-H007.
Zhang ZL; Liu WQ; Deng XZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8939-8950. PubMed ID: 30575938
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of 2',3',5'-tri-O-acetyl-N6-(3-hydroxylaniline)adenosine and its principal metabolites in hamster blood by LC-MS/MS and its application in pharmacokinetics study.
Jia Y; Wang B; Wu X; Li S; Hu J; Wang D; Zhu H; Li Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():46-53. PubMed ID: 27082762
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Metabolic Effects of 2',3',5'-Triacetyl-N
Li T; Sun S; Zhang J; Qu K; Yang L; Ma C; Jin X; Zhu H; Wang Y
J Proteome Res; 2018 Aug; 17(8):2870-2879. PubMed ID: 29925242
[TBL] [Abstract][Full Text] [Related]
4. IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet.
Shi H; Wang Q; Yang L; Xie S; Zhu H
FEBS Open Bio; 2017 Sep; 7(9):1379-1391. PubMed ID: 28904866
[TBL] [Abstract][Full Text] [Related]
5. The cordycepin derivative IMM-H007 improves endothelial dysfunction by suppressing vascular inflammation and promoting AMPK-dependent eNOS activation in high-fat diet-fed ApoE knockout mice.
Wang MJ; Peng XY; Lian ZQ; Zhu HB
Eur J Pharmacol; 2019 Jun; 852():167-178. PubMed ID: 30826323
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of in vitro and in vivo metabolites of 2',3',5'‑tri‑O‑acetyl‑N
Jin M; Guo N; Li T; Liu X; Sun S; Jin X; Zhu H; Qin H; Wang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1096():187-200. PubMed ID: 30176508
[TBL] [Abstract][Full Text] [Related]
7. IMM-H007 improves heart function via reducing cardiac fibrosis.
Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
[TBL] [Abstract][Full Text] [Related]
8. IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway.
Wang SX; Feng YN; Feng S; Wu JM; Zhang M; Xu WL; Zhang YY; Zhu HB; Xiao H; Dong ED
Acta Pharmacol Sin; 2022 Oct; 43(10):2542-2549. PubMed ID: 35354962
[TBL] [Abstract][Full Text] [Related]
9. A novel AMPK activator improves hepatic lipid metabolism and leukocyte trafficking in experimental hepatic steatosis.
Peng X; Li J; Wang M; Qu K; Zhu H
J Pharmacol Sci; 2019 Jun; 140(2):153-161. PubMed ID: 31253430
[TBL] [Abstract][Full Text] [Related]
10. IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling.
Yu J; Ming H; Li HY; Yu B; Chu M; Zhu H; Zhu X
Toxicol Appl Pharmacol; 2019 Oct; 381():114732. PubMed ID: 31454633
[TBL] [Abstract][Full Text] [Related]
11. Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
Liu L; Yin X; Wang X; Li X
Pharm Biol; 2017 Dec; 55(1):657-662. PubMed ID: 27951743
[TBL] [Abstract][Full Text] [Related]
12. In-situ absorption, protein binding and pharmacokinetic studies of S002-853, a novel antidiabetic and antidyslipidaemic flavone derivative in rats.
Gautam N; Kushwaha HN; Pratap R; Singh SK
J Pharm Pharmacol; 2010 May; 62(5):604-9. PubMed ID: 20609062
[TBL] [Abstract][Full Text] [Related]
13. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125.
Kawai R; Lemaire M; Steimer JL; Bruelisauer A; Niederberger W; Rowland M
J Pharmacokinet Biopharm; 1994 Oct; 22(5):327-65. PubMed ID: 7791036
[TBL] [Abstract][Full Text] [Related]
16. Determination of cepharanthine in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
Deng Y; Wu W; Ye S; Wang W; Wang Z
Pharm Biol; 2017 Dec; 55(1):1775-1779. PubMed ID: 28521597
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
Deng G; Liu W; Ma C; Rong X; Zhang Y; Wang Y; Wu C; Cao N; Ding W; Guan H; Cheng X; Wang C
J Ethnopharmacol; 2019 May; 236():288-301. PubMed ID: 30872168
[TBL] [Abstract][Full Text] [Related]
18. Determination of IMM-H004 and its active glucuronide metabolite in rat plasma and Ringer's solution by ultra-performance liquid chromatography-tandem mass spectrometry.
Jiang J; Zhang Z; Zou X; Wang R; Bai J; Zhao S; Fan X; Sheng L; Li Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():16-24. PubMed ID: 29329091
[TBL] [Abstract][Full Text] [Related]
19. First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method.
Baira SM; Khurana A; Somagoni J; Srinivas R; Godugu C; Talluri MVNK
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():191-198. PubMed ID: 29908468
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, bioavailability and tissue distribution study of JCC-02, a novel N-methyl-d-aspartate (NMDA) receptor inhibitor, in rats by LC-MS/MS.
Yang T; Shi Y; Lin C; Yan C; Zhang D; Lin J
Eur J Pharm Sci; 2019 Apr; 131():146-152. PubMed ID: 30776467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
